col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


78 Results       Page 1

 [1] 
Ovid: Journal of Addiction Medicine
  original article Date Title Authors   Max. 6 Authors
1 [GO] 2024―Mar―13 Real-World Evidence for Impact of Opioid Agonist Therapy on Nonfatal Overdose in Patients With Opioid Use Disorder During the COVID-19 Pandemic: Erratum
2 [GO] 2024―Feb―12 North Carolina Medicaid System Perspectives on Substance Use Disorder Treatment Policy Changes during the COVID-19 Pandemic Phillip M. Hughes, Caleb W. Easterly, Kathleen C. Thomas, Christopher M. Shea, Marisa Elena Domino
3 [GO] 2023―Sep―26 Effect of COVID-19 on the Long-term Cardiovascular Outcomes among Patients with Alcohol Use Disorder: A Retrospective Cohort Study Including 45,842 Patients Ting-Hui Liu, Jheng-Yan Wu, Po-Yu Huang, Ya-Wen Tsai, Chih-Cheng Lai
4 [GO] 2023―Sep―26 Decline in Prenatal Buprenorphine/Naloxone Fills during the COVID-19 Pandemic in the United States Ashley L. O’Donoghue, Alyse Reichheld, Timothy S. Anderson, Chloe A. Zera, Tenzin Dechen, Jennifer P. Stevens
5 [GO] 2023―Aug―11 Telehealth-delivered Psychotherapy for the Treatment of Alcohol Use Disorder: Patient Perspectives in the Age of COVID-19 Rachel Girard, Jane Foreman, Ellen Pinnette, Erin E. Bonar, Anne Fernandez, Lewei (Allison) Lin
6 [GO] 2023―Aug―11 Real-world Evidence for Impact of Opioid Agonist Therapy on Nonfatal Overdose in Patients with Opioid Use Disorder during the COVID-19 Pandemic Kenneth Lee, Yue Zhao, Tazmin Merali, Christopher Fraser, Jan-Marie Kozicky, Marie-Christine Mormont, Brian Conway
7 [GO] 2023―Mar―31 Integrating Text Messaging in a Low Threshold Telebuprenorphine Program for New York City Residents with Opioid Use Disorder during COVID-19: A Pilot Randomized Controlled Trial Babak Tofighi, Beita Badiei, Ryan Badolato, Crystal Fuller Lewis, Edward Nunes, Anil Thomas, Joshua D. Lee
8 [GO] 2023―Mar―10 High Primary COVID-19 Vaccine Series Completion by People Who Inject Drugs When Colocating Services at a Syringe Services Van Omeid Heidari, Katie J. O’Conor, Diane Meyer, Victoria Cargill, Kelly Lowensen, Jason E. Farley
9 [GO] 2023―Mar―02 Clinician Perspectives on Delivering Medication Treatment for Opioid Use Disorder during the COVID-19 Pandemic: A Qualitative Evaluation Aline M. Lott, Anissa N. Danner, Carol A. Malte, Emily C. Williams, Adam J. Gordon, Max A. Halvorson, Andrew J. Saxon, Hildi J. Hagedorn, George G. Sayre, Eric J. Hawkins
10 [GO] 2023―Feb―02 Individuals Reporting Past 3-month Smoked Stimulant Use Are Placed at Risk for Infection and Injury Amid COVID-19 Dinah Applewhite, Susan Regan, Sarah Mackin, Clare Schmidt, Jim Duffy, Kenneth Washington, Nathaneal Micklos, Sarah Casey, Samantha Sawyer, Laura Kehoe, Sydney Howard, Giovanie Yacorps, Sarah E. Wakeman
11 [GO] 2023―Feb―02 Pandemics Interlaced: The Impact of the COVID-19 Pandemic on the Wellbeing of Sober Living Home Residents Grace Noonan, Jason Glenn
12 [GO] 2023―Feb―02 Assessment of COVID-19-Driven Changes in an Integrated OBGYN-Addiction Treatment Clinic and Future Implications Sumaya Smarony, Anna Beth Parlier-Ahmad, Hannah Shadowen, Bhushan Thakkar, Marjorie O. Scheikl, Caitlin E. Martin
13 [GO] 2023―Feb―02 Pregnancy, Opioid Use Disorder and COVID-19: An Evaluation of Acute Care Presentations During a Pandemic Elizabeth Gill, Anupa D. Ghimire, Derek A. Robinett, James S. Booth, Lauren A. Walter
14 [GO] 2022―Oct―18 Struggling With Recovery From Opioids: Who Is at Risk During COVID-19? Diana R. Keith, Allison N. Tegge, Jeffrey S. Stein, Liqa N. Athamneh, William H. Craft, Howard D. Chilcoat, Anne Le Moigne, Angela DeVeaugh-Geiss, Warren K. Bickel
15 [GO] 2022―Sep―21 Implementation of Telemedicine Delivery of Medications for Opioid Use Disorder in Pennsylvania Treatment Programs During COVID-19 Melissa N. Poulsen, William Santoro, Roseanne Scotti, Catherine Henderson, Meaghan Ruddy, Angela Colistra
16 [GO] 2022―Sep―09 Increased Difficulties Managing Chronic Medical Conditions During the COVID-19 Pandemic Are Associated With Increased Alcohol and Cannabis Use Among Unhoused and Unstably Housed Women Elise D. Riley, Leah Warner, Judith A. Hahn, Carl Braun, Samantha Dilworth, Barry Zevin, Torsten B. Neilands, Sheri D. Weiser
17 [GO] 2022―Aug―02 Low Threshold Telemedicine-based Opioid Treatment for Criminal Justice Involved Adults During the COVID-19 Pandemic: A Case Report: Erratum
18 [GO] 2022―Aug―02 Syringe Service Program Perspectives on Barriers, Readiness, and Programmatic Needs to Support Rollout of the COVID-19 Vaccine Maria A. Corcorran, Elizabeth J. Austin, Czarina N. Behrends, Elsa S. Briggs, Madeline C. Frost, Alexa M. Juarez, Noah D. Frank, Elise Healy, Stephanie M. Prohaska, Paul A. LaKosky, Shashi N. Kapadia, David C. Perlman, Bruce R. Schackman, Don C. Des Jarlais, Emily C. Williams, Sara N. Glick
19 [GO] 2022―Jul―21 Alcohol Consumption During the First Year of the COVID-19 Pandemic in the United States: Results From a Nationally Representative Longitudinal Survey Carolina Barbosa, William N. Dowd, Alan Barnosky, Katherine J. Karriker-Jaffe
20 [GO] 2022―Jul―15 Providing Low-barrier Addiction Treatment Via a Telemedicine Consultation Service During the COVID-19 Pandemic in Los Angeles, County: An Assessment 1 Year Later Amy J. Kennedy, James S. George, Gina Rossetti, Christopher O. Brown, Kyle Ragins, David Dadiomov, Rebecca Trotzky-Sirr, Gloria Sanchez, Herman Llamas, Brian Hurley
21 [GO] 2022―Jul―07 COVID-19 Vaccination Status and Concerns Among People Who Use Drugs in Oregon Erin Stack, Sarah Shin, Kate LaForge, Justine Pope, Gillian Leichtling, Jessica E. Larsen, Mikaela Byers, Judith M. Leahy, Daniel Hoover, Laura Chisholm, P. Todd Korthuis
22 [GO] 2022―Jun―24 Changes in Alcohol Consumption by Beverage Type Attributable to the COVID-19 Pandemic for 10 States, March 2020 to November 2020: An Ecological Simulation-based Analysis Jarratt D. Pytell, Ashish P. Thakrar, Geetanjali Chander, Elizabeth Colantuoni
23 [GO] 2022―Mar―11 HIV Exposure Prophylaxis Delivery in a Low-barrier Substance Use Disorder Bridge Clinic During a Local HIV Outbreak at the Onset of the COVID-19 Pandemic Hannan M. Braun, Chelsea Walter, Natalija Farrell, Katie B. Biello, Jessica L. Taylor
24 [GO] 2022―Feb―23 Patient Characteristics Associated With Phone Versus Video Telemedicine Visits for Substance Use Treatment During COVID-19 Ji Eun Chang, Zoe Lindenfeld, Tatiana Thomas, Justine Waldman, Judith Griffin
25 [GO] 2022―Feb―15 Changes in Cannabis Use Risk Behaviors During the First and Second COVID-19 Lockdown in Israel Sharon R. Sznitman
26 [GO] 2022―Feb―15 Shifting Medication Treatment Practices in the COVID-19 Pandemic Noa Krawczyk, Hannah Maniates, Eric Hulsey, Jennifer S. Smith, Ellen DiDomenico, Elizabeth A. Stuart, Brendan Saloner, Sachini Bandara
27 [GO] 2022―Feb―12 Supporting Self-isolation for COVID-19 With “Risk Mitigation” Prescribing and Housing Supports for People Who Use Drugs Ran Ha Hong, Rupinder Brar, Nadia Fairbairn
28 [GO] 2022―Feb―04 A Case of Phenibut Directed Detoxification Leading to Toxicity During the COVID-19 Pandemic Alyssa F. Peterkin, Rohit Abraham, Miriam T.H. Harris
29 [GO] 2022―Jan―12 Adaptations to Opioid Use Disorder Care During the COVID-19 Pandemic Minhee L. Sung, Anne C. Black, Derek Blevins, Brandy F. Henry, Kathryn Cates-Wessel, Michael A. Dawes, Karen Drexler, Holly Hagle, Todd Molfenter, Frances R. Levin, William C. Becker, E. Jennifer Edelman
30 [GO] 2021―Nov―18 Factors Associated With Increased Opioid Use During the COVID-19 Pandemic Tea Rosic, Leen Naji, Nitika Sanger, David C. Marsh, Andrew Worster, Lehana Thabane, Zainab Samaan
31 [GO] 2021―Jun―26 During the COVID-19 Pandemic, Opioid Overdose Deaths Revert to Previous Record Levels in Ohio Jamie Vieson, Arthur B. Yeh, Qizhen Lan, Jon E. Sprague
32 [GO] 2021―Jun―19 Harnessing the Power of Social Media to Understand the Impact of COVID-19 on People Who Use Drugs During Lockdown and Social Distancing Nabila El-Bassel, Karli R. Hochstatter, Melissa N. Slavin, Chenghao Yang, Yudong Zhang, Smaranda Muresan
33 [GO] 2021―May―04 The Role of Alcohol Biomarkers in Detecting a Physician's COVID-19-Related Acute Stress Response Alexis G. Polles, William S. Jacobs, Chad Brazle, Lisa J. Merlo
34 [GO] 2021―Apr―26 Social Determinants of Mortality of COVID-19 and Opioid Overdose in American Rural and Urban Counties Yuhui Zhu, Zhe Fei, Larissa J. Mooney, Kaitlyn Huang, Yih-Ing Hser
35 [GO] 2021―Apr―20 Opioid-related Emergency Department Visits During COVID-19 in a Large Health System Gavin T. Hall, Daniel S. Cruz, Patrick M. Lank, Danielle M. McCarthy, Howard S. Kim
36 [GO] 2021―Apr―20 Virtual Twelve Step Meeting Attendance During the COVID-19 Period Marc Galanter, William L. White, Brooke Hunter
37 [GO] 2021―Apr―12 Barriers to Care Experienced by Patients Who Inject Drugs During the COVID-19 Pandemic Emily Gleason, Nathanial S. Nolan, Laura R. Marks, Tracey Habrock, Stephen Y. Liang, Michael J. Durkin
38 [GO] 2021―Mar―26 The Relationship Between Children's Problematic Internet-related Behaviors and Psychological Distress During the Onset of the COVID-19 Pandemic Chao-Ying Chen, I-Hua Chen, Wen-Li Hou, Marc N. Potenza, Kerry S. O’Brien, Chung-Ying Lin, Janet D. Latner
39 [GO] 2021―Mar―24 Low Threshold Telemedicine-based Opioid Treatment for Criminal Justice Involved Adults During the COVID-19 Pandemic Lila Flavin, Babak Tofighi, Noa Krawczyk, Daniel Schatz, Jennifer McNeely, Jenna Butner
40 [GO] 2021―Feb―27 Low-Threshold Buprenorphine via Community Partnerships and Telemedicine-Case Reports of Expanding Access to Addiction Treatment During COVID-19 Ximena A. Levander, Haven Wheelock, Justine Pope, Abby Lee, Kerith Hartmann, Sarah Abuelkhair, Jessica L. Gregg, Bradley M. Buchheit
41 [GO] 2021―Feb―21 Treatment Disruption and Childcare Responsibility as Risk Factors for Drug and Alcohol Use in Persons in Treatment for Substance Use Disorders During the COVID-19 Crisis Andrew S. Huhn, Eric C. Strain, Jasmyne Jardot, Gavin Turner, Cecilia L. Bergeria, Sandeep Nayak, Kelly E. Dunn
42 [GO] 2021―Feb―21 Reduction in Oregon's Medication Dosing Visits After the SARS-CoV-2 Relaxation of Restrictions on Take-home Medication John W. McIlveen, Kim Hoffman, Kelsey C. Priest, Dongseok Choi, Phillip Todd Korthuis, Dennis McCarty
43 [GO] 2021―Feb―06 Factors Associated With Drug Overdoses During the COVID-19 Pandemic Alexandra M. Mellis, Braeden C. Kelly, Marc N. Potenza, Jessica N. Hulsey
44 [GO] 2020―Dec―15 Barriers and Facilitators to Buprenorphine Prescribing for Opioid Use Disorder in the Veterans Health Administration During COVID-19 A. Taylor Kelley, Matthew T. Dungan, Adam J. Gordon
45 [GO] 2020―Dec―15 COVID-19 and Cannabidiol (CBD) Jag H. Khalsa, Greg Bunt, Sanjay B. Maggirwar, Shyam Kottilil
46 [GO] 2020―Dec―15 Cannabis Use During the COVID-19 Pandemic in Canada Sameer Imtiaz, Samantha Wells, Jürgen Rehm, Hayley A. Hamilton, Yeshambel T. Nigatu, Christine M. Wickens, Damian Jankowicz, Tara Elton-Marshall
47 [GO] 2020―Dec―15 Impacts of the COVID-19 Shutdown on Gambling Patterns in Australia Sally M. Gainsbury, Thomas B. Swanton, Martin T. Burgess, Alex Blaszczynski
48 [GO] 2020―Dec―15 COVID-19 Social Distancing and Online Mutual Help Engagement for Alcohol Use Recovery Jason B. Colditz, Scott D. Rothenberger, Jane M. Liebschutz, Bruce L. Rollman, Kevin L. Kraemer
49 [GO] 2020―Dec―10 Adaptation of a System of Treatment for Substance Use Disorders During the COVID-19 Pandemic Miriam Komaromy, Mary Tomanovich, Jessica L. Taylor, Glorimar Ruiz-Mercado, Simeon D. Kimmel, Sarah M. Bagley, Kelley M. Saia, Eileen Costello, Tae Woo Park, Colleen LaBelle, Zoe Weinstein, Alexander Y. Walley
50 [GO] 2020―Nov―24 Treating Opioid Use Disorder in Puerto Rico During the COVID-19 Pandemic Darlene Santiago Quiñones, Kyle Melin, Luis Roman, Francisco Rodriguez, Jose Alvarado, Carlos E. Rodríguez-Díaz
51 [GO] 2020―Nov―19 The Impact of COVID-19 on Service Provision for Emergency Department Patients Post-Opioid Overdose Alexandra B. Collins, Francesca L. Beaudoin, Elizabeth A. Samuels, Rachel Wightman, Janette Baird
52 [GO] 2020―Nov―11 Adapting a Low-threshold Buprenorphine Program for Vulnerable Populations During the COVID-19 Pandemic Courtney D. Nordeck, Megan Buresh, Noa Krawczyk, Michael Fingerhood, Deborah Agus
53 [GO] 2020―Nov―06 The Impacts of COVID-19 on Mental Health, Substance Use, and Overdose Concerns of People Who Use Drugs in Rural Communities Erin Stack, Gillian Leichtling, Jessica E. Larsen, Mary Gray, Justine Pope, Judith M. Leahy, Lillian Gelberg, Andrew Seaman, Philip Todd Korthuis
54 [GO] 2020―Nov―04 Treatment for Anxiety and Substance Use Disorders During the COVID-19 Pandemic: Challenges and Strategies Derek D. Satre, Esti Iturralde, Murtuza Ghadiali, Kelly C. Young-Wolff, Cynthia I. Campbell, Amy S. Leibowitz, Stacy A. Sterling
55 [GO] 2020―Oct―26 Rapid Transition of Individual and Group-based Behavioral Outpatient Visits to Telepsychiatry in Response to COVID-19 Erin L. Winstanley, Laura R. Lander, Wanhong Zheng, Kari-Beth Law, Ashley Six-Workman, James H. Berry
56 [GO] 2020―Oct―26 Alcohol Consumption in Response to the COVID-19 Pandemic in the United States Carolina Barbosa, Alexander J. Cowell, William N. Dowd
57 [GO] 2020―Oct―08 Naloxone Use by Emergency Medical Services During the COVID-19 Pandemic David C. Cone, Sandy Bogucki, Kevin Burns, Gail D’Onofrio, Kathryn Hawk, Daniel Joseph, David A. Fiellin
58 [GO] 2020―Oct―08 Impact of COVID-19 Related Policy Changes on Buprenorphine Dispensing in Texas James Douglas Thornton, Tyler J. Varisco, Shweta S. Bapat, Callie G. Downs, Chan Shen
59 [GO] 2020―Oct―06 MOUD Provision in Correctional Settings During Time of COVID-19 Nickolas Zaller, Lauren Brinkley-Rubinstein
60 [GO] 2020―Oct―03 Access to Healthcare and Harm Reduction Services During the COVID-19 Pandemic for People Who Use Drugs MJ Stowe, Tanya Calvey, Florian Scheibein, Sidharth Arya, Noha Ahmed Saad, Tomohiro Shirasaka, Lisa Dannatt, Abhishek Ghosh, Anne Yee, Woraphat Ratta-apha, Ramyadarshni Vadivel, Kristiana Siste, Bigya Shah, Rodrigo Ramalho, Venkata Lakshmi Narasimha, Mirjana Delic, Eric Peyron, Joy Louise Gumikiriza- Onoria, Sagun Ballav Pant, Saïd Boujraf, Paolo Grandinetti, Nirvana Morgan
61 [GO] 2020―Oct―03 Telehealth Capability Among Substance Use Disorder Treatment Facilities in Counties With High Versus Low COVID-19 Social Distancing Jonathan Cantor, Bradley D. Stein, Brendan Saloner
62 [GO] 2020―Sep―20 Digital Clinical Trials for Substance Use Disorders in the Age of Covid-19 Christina A. Brezing, Sean X. Luo, John J. Mariani, Frances R. Levin
63 [GO] 2020―Sep―16 Preferences for Tobacco Cessation Information and Support During Covid-19 Simone Pettigrew, Min Jun, Ian Roberts, Chris Bullen, Kellie Nallaiah, Anthony Rodgers
64 [GO] 2020―Sep―09 The Changing Landscape of Alcohol Use and Alcohol Use Disorder During the COVID-19 Pandemic - Perspectives of Early Career Professionals in 16 Countries Tanya Calvey, Florian Scheibein, Noha Ahmed Saad, Tomohiro Shirasaka, Lisa Dannatt, MJ Stowe, Bigya Shah, Venkata Lakshmi Narasimha, Angelo Bruschi, Eric Peyron, Joy Louise Gumikiriza-Onoria, Abhishek Ghosh, Sagun Ballav Pant, Anne Yee, Woraphat Ratta-apha, Ramyadarshni Vadivel, Kristiana Siste, Tanay Maiti, Saïd Boujraf, Paolo Grandinetti, Nirvana Morgan, Sidharth Arya
65 [GO] 2020―Aug―30 Early Effects of COVID-19 on Programs Providing Medications for Opioid Use Disorder in Jails and Prisons Sachini Bandara, Alene Kennedy-Hendricks, Sydney Merritt, Colleen L. Barry, Brendan Saloner
66 [GO] 2020―Aug―27 A Case Report of Isopropanol Ingestion During the SARS-CoV-2 Pandemic Caroline P. Meehan, Rachel S. Wightman
67 [GO] 2020―Aug―21 Policies to Improve Substance Use Disorder Treatment With Telehealth During the COVID-19 Pandemic and Beyond Coleman Drake, Jiani Yu, Nicole Lurie, Kevin Kraemer, Daniel Polsky, Krisda H. Chaiyachati
68 [GO] 2020―Aug―08 Opioid Use Disorder in the Emergency Department Amid COVID-19 Lauren A. Walter, Li Li
69 [GO] 2020―Aug―08 Calls for Access to Safe Injecting Supplies as a Critical Public Health Measure During the COVID-19 Pandemic Koharu Loulou Chayama, Cara Ng, Ryan McNeil
70 [GO] 2020―Jun―24 COVID-19 as a Frying Pan Brandon del Pozo, Leo Beletsky, Josiah D. Rich
71 [GO] 2020―Jun―11 Prevalence of Covid-19 Infection and Subsequent Cohorting in a Residential Substance Use Treatment Program in Boston, MA Joshua A. Barocas, Elizabeth Blackstone, Tara C. Bouton, Simeon D. Kimmel, Andrea Caputo, Sarah J. Porter, Alexander Y. Walley
72 [GO] 2020―Jun―01 Will the Current COVID-19 Pandemic Impact on Long-Term Cannabis Buying Practices? Teodora Groshkova, Tiberiu Stoian, Andrew Cunningham, Paul Griffiths, Nicola Singleton, Roumen Sedefov
73 [GO] 2020―May―26 Low Barrier Tele-Buprenorphine in the Time of COVID-19 Miriam Harris, Samantha Johnson, Sarah Mackin, Richard Saitz, Alexander Y. Walley, Jessica L. Taylor
74 [GO] 2020―May―26 Gambling during the COVID-19 crisis - A cause for concern? Anders Håkansson, Fernando Fernández-Aranda, Jose M. Menchón, Marc N. Potenza, Susana Jiménez-Murcia
75 [GO] 2020―May―26 Opioid Policy Changes During the COVID-19 Pandemic - and Beyond Corey S. Davis, Elizabeth A. Samuels
76 [GO] 2020―May―14 Innovation During COVID-19 Elizabeth A. Samuels, Seth A. Clark, Caroline Wunsch, Lee Ann Jordison Keeler, Neha Reddy, Rahul Vanjani, Rachel S. Wightman
77 [GO] 2020―May―14 Opioid Use Disorder and COVID-19 Utsha G. Khatri, Jeanmarie Perrone
78 [GO] 2020―May―14 Optimizing Medication Treatment of Opioid Use Disorder During COVID-19 (SARS-CoV-2) Idris E. Leppla, Marielle S. Gross
 [1] 

78 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.006 sec